|Dr. Reza Zadno Ph.D.||Pres, CEO & Director||652.8k||N/A||1955|
|Mr. Kevin Waters||Sr. VP & CFO||565.38k||N/A||1977|
|Mr. Hisham Shiblaq||Sr. VP of Global Commercialization||450.23k||N/A||1975|
|Mr. Mohan F. Sancheti||VP of Operations||N/A||N/A||1964|
|Ms. Alaleh Nouri||Sr. VP, Gen. Counsel & Corp. Sec.||N/A||N/A||1979|
|Ms. Minni Vittal||VP of People||N/A||N/A||N/A|
|Mr. Surag Mantri||Sr. VP of R&D||N/A||N/A||N/A|
PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in Redwood City, California.
PROCEPT BioRobotics Corporation’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.